The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective

Table 2 All-cause health care resource use among patients with HCV and ALD (cases) and matched patients with HCV and no ALD (comparison)

	Patients with HCV and ALD (Cases)	Patients with HCV and without ALD (Comparison)	Difference	P-value¹
N	1,193	1,193
Inpatient
Percent with ≥1 hospitalization (1 yr follow-up)	73.6%	27.1%	46.5%	< .001
Hospital admissions (PPPM)				< .001
Mean	0.3	0.1	0.3
SD	0.4	0.1
Median	0.2	0.0
Hospital days (PPPM)				< .001
Mean	1.9	0.3	1.6
SD	2.9	0.8
Median	0.7	0.0
Outpatient Services²
Percent with ≥1 outpatient service (1 yr follow-up)	99.2%	96.1%	3.1%	< .001
Outpatient office/clinic services (PPPM)				< .001
Mean	19.4	4.1	15.3
SD	24.2	4.7
Median	10.4	2.6
Pharmacy
Percent with ≥1 medication dispensed (1 yr follow-up)	89.8%	92.0%	−2.2%	0.064
Medications dispensed (PPPM)				0.010
Mean	5.8	5.4	0.4
SD	4.5	4.3
Median	5.2	4.6
Other Services³
Percent with at least 1 other resource use claim	91.3%	88.4%	2.9%	0.025

Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.
Notes: Percentages are those with the resource use of interest at any time during the year.
¹ Calculated with the Fisher Exact 2-tailed test used for comparison of proportions, and the Wilcoxon test for comparison of means.
² Patients may have received multiple outpatient services on the same day, including hospital outpatient, physician, nurse practitioner, physician assistant, clinic, or other outpatient services.
³ "Other" services include nursing home, home health, hospice, and other services.
ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.

ISSN: 1472-6963